Both in Biotechnology
Intensity Therapeutics vs IN8bio
Over the past year INTS returned −46.3% and INAB returned −51.4%; their daily moves had a correlation of 0.07.
INTS −46.3% INAB −51.4%Growth of $1, one year, split-adjusted
| Metric | INTS | INAB |
|---|---|---|
| Price | $3.38 | $1.02 |
| Market cap | $11.0M | $10.1M |
| Today | +6.29% | +6.25% |
| 1 month | −1.2% | −21.2% |
| 6 months | −34.4% | −32.5% |
| Year to date | −67.0% | −56.4% |
| 1 year | −44.7% | −51.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.5M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 62.5% | 82.1% |
| Short % of float | 2.9% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).